Oncopeptides AB (publ) (ONPPF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -249.11 Million SEK | 26.29% |
| 2022 | -337.95 Million SEK | 76.37% |
| 2021 | -1.43 Billion SEK | 10.31% |
| 2020 | -1.59 Billion SEK | -115.29% |
| 2019 | -740.7 Million SEK | -76.59% |
| 2018 | -419.44 Million SEK | -69.39% |
| 2017 | -247.62 Million SEK | -116.36% |
| 2016 | -114.44 Million SEK | -114.56% |
| 2015 | -53.34 Million SEK | -61.18% |
| 2014 | -33.09 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -73.24 Million SEK | -8.18% |
| 2024 Q1 | -67.7 Million SEK | 16.63% |
| 2023 Q2 | -56.33 Million SEK | 20.69% |
| 2023 Q3 | -40.54 Million SEK | 28.03% |
| 2023 Q1 | -71.02 Million SEK | 22.03% |
| 2023 Q4 | -81.21 Million SEK | -100.31% |
| 2023 FY | -249.11 Million SEK | 26.29% |
| 2022 Q1 | -98.58 Million SEK | 74.98% |
| 2022 FY | -337.95 Million SEK | 76.37% |
| 2022 Q2 | -59.82 Million SEK | 39.32% |
| 2022 Q4 | -91.09 Million SEK | -3.01% |
| 2022 Q3 | -88.43 Million SEK | -47.82% |
| 2021 Q4 | -393.99 Million SEK | 49.33% |
| 2021 FY | -1.43 Billion SEK | 10.31% |
| 2021 Q1 | -234.66 Million SEK | 54.25% |
| 2021 Q2 | -24.11 Million SEK | 89.72% |
| 2021 Q3 | -777.54 Million SEK | -3124.2% |
| 2020 Q4 | -512.96 Million SEK | -33.81% |
| 2020 Q3 | -383.35 Million SEK | 4.41% |
| 2020 Q1 | -297.32 Million SEK | -21.41% |
| 2020 FY | -1.59 Billion SEK | -115.29% |
| 2020 Q2 | -401.04 Million SEK | -34.88% |
| 2019 Q3 | -189.78 Million SEK | -10.37% |
| 2019 FY | -740.7 Million SEK | -76.59% |
| 2019 Q4 | -244.9 Million SEK | -29.05% |
| 2019 Q2 | -171.94 Million SEK | -40.71% |
| 2019 Q1 | -122.19 Million SEK | -9.73% |
| 2018 Q1 | -62.03 Million SEK | 7.0% |
| 2018 FY | -419.44 Million SEK | -69.39% |
| 2018 Q4 | -111.36 Million SEK | -8.14% |
| 2018 Q3 | -102.98 Million SEK | 28.02% |
| 2018 Q2 | -143.07 Million SEK | -130.65% |
| 2017 Q4 | -66.7 Million SEK | -29.34% |
| 2017 Q1 | -62.08 Million SEK | -21.61% |
| 2017 Q2 | -67.26 Million SEK | -8.34% |
| 2017 Q3 | -51.57 Million SEK | 23.32% |
| 2017 FY | -247.62 Million SEK | -116.36% |
| 2016 Q1 | -15.24 Million SEK | 0.0% |
| 2016 Q2 | -23.48 Million SEK | -54.05% |
| 2016 Q4 | -51.05 Million SEK | -106.96% |
| 2016 FY | -114.44 Million SEK | -114.56% |
| 2016 Q3 | -24.66 Million SEK | -5.04% |
| 2015 FY | -53.34 Million SEK | -61.18% |
| 2014 FY | -33.09 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.17 Million USD | -7754.833% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -6614.159% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -10363.024% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 570.207% |
| GB Sciences, Inc. | -1.36 Million USD | -18194.427% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -8131.986% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -109098.385% |
| Skye Bioscience, Inc. | -37.64 Million USD | -561.741% |
| Zenith Capital Corp. | -10.59 Million USD | -2250.991% |
| Agentix Corp. | -1.37 Million USD | -18027.566% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -3467.476% |
| Biomind Labs Inc. | -1.21 Million USD | -20414.461% |
| ContraFect Corporation | -65.15 Million USD | -282.348% |
| CSL Limited | 2.64 Billion USD | 109.429% |
| CytoDyn Inc. | -49.84 Million USD | -399.811% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -12679.845% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -39290.93% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -297.947% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -59857.543% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -13583.448% |
| Regen BioPharma, Inc. | 1.02 Million USD | 24438.94% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 482.466% |
| SQZ Biotechnologies Company | -79.46 Million USD | -213.489% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -11380.754% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -232.312% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -8512.623% |
| Mesoblast Limited | -87.95 Million USD | -183.222% |
| Marizyme, Inc. | -65.34 Million USD | -281.213% |
| Genus plc | 7.9 Million USD | 3253.304% |
| Pharming Group N.V. | -10.54 Million USD | -2261.689% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -2716.723% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -14320.694% |
| IMV Inc. | -36.48 Million USD | -582.763% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -2990.829% |
| MultiCell Technologies, Inc. | -380.07 USD | -65543352.522% |
| ONE Bio Corp. | 8.67 Million USD | 2971.063% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -381.914% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -6573.212% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -7931.258% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -3052.07% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -1663301.442% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -1469.555% |
| Alpha Cognition Inc. | -13.77 Million USD | -1708.748% |
| Enzolytics Inc. | -2.17 Million USD | -11343.74% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 15.571% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 254294.898% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 3697.482% |
| Genscript Biotech Corporation | -95.47 Million USD | -160.912% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -3688.12% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -91015.281% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -5908.559% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -412058.315% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -12323.776% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -2187.155% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -4998.399% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -6549.31% |
| Helix BioMedix, Inc. | -1.05 Million USD | -23488.784% |
| EV Biologics, Inc. | -1.26 Million USD | -19559.405% |
| Q BioMed Inc. | -2.05 Million USD | -12039.362% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -6422.938% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -317.094% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -2836.596% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -4182.279% |
| HST Global, Inc. | -146.21 Thousand USD | -170278.907% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -18553.978% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -14096.211% |
| Halberd Corporation | -79.67 Thousand USD | -312555.003% |
| Resverlogix Corp. | -3.61 Million USD | -6800.582% |
| Cell Source, Inc. | -5.32 Million USD | -4581.471% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -6170.109% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.41 Million USD | -3784.077% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -1071713.957% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -5123.343% |
| Kadimastem Ltd | -3.3 Million USD | -7431.933% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -5507.407% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -56340.529% |
| LadRx Corporation | 400.44 Thousand USD | 62308.854% |
| Regen BioPharma, Inc. | 1.02 Million USD | 24438.94% |
| Affymax, Inc. | -14.42 Million USD | -1627.059% |
| Itoco Inc. | -1.86 Million USD | -13228.607% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -14825.764% |
| Mobile Lads Corp. | -2.26 Million USD | -10906.578% |
| International Stem Cell Corporation | -131 Thousand USD | -190061.069% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -4.28 Million USD | -5720.348% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -315098.714% |
| Qrons Inc. | -789.34 Thousand USD | -31459.124% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -26358.134% |
| SYBLEU INC | -180.3 Thousand USD | -138061.66% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -11832.421% |
| Rebus Holdings, Inc. | -1.02 Million USD | -24322.647% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -15346.474% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -458904.643% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -9745.323% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -418.204% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -11683.869% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -31801.03% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -7763.352% |
| Neutra Corp. | -233.46 Thousand USD | -106601.647% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1127.692% |
| PureTech Health plc | -65.69 Million USD | -279.182% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -1071.375% |
| IXICO plc | -1.17 Million USD | -21046.944% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -2409.429% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -336.058% |
| CSL Limited | 2.64 Billion USD | 109.429% |
| Cellectis S.A. | -103.17 Million USD | -141.448% |